🔎 Trials Near Me

Hjem › Melanom › Ohio › Columbus

Kliniske studier for Melanom i Columbus, OH

21 studier for Melanom søker deltakere på steder i og rundt Columbus (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • og 8 flere
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

RekruttererFase 3
  • The Ohio State University Wexner Medical Center, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

RekruttererFase 3
  • Ohio State University, Columbus
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

RekruttererFase 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 75 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07068074

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

RekruttererFase 1
  • Ohio State University, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06529822

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

RekruttererFase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • og 15 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

RekruttererObservasjonsstudie
  • Nationwide Children's Hospital, Columbus
  • Ohio State University Comprehensive Cancer Center, Columbus
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

RekruttererFase 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 til 99 · Alle kjønn · Oppdatert 13. jul. 2026 · NCT04697576

Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain

RekruttererFase 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 11. jun. 2026 · NCT05588453

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

RekruttererFase 1/2
  • Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

RekruttererFase 3
  • Ohio State Eye and Ear Institute, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT07015190

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RekruttererObservasjonsstudie
  • Memorial Hospital, Marysville · 27 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06418204

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

RekruttererFase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 til 99 · Alle kjønn · Oppdatert 10. mar. 2026 · NCT06223659

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • The Ohio State University Wexner Medical Center, Columbus
Alle aldre · Alle kjønn · Oppdatert 9. mar. 2026 · NCT04792463

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

RekruttererFase 3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 25. feb. 2026 · NCT05549297

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Ohio State University Comprehensive Cancer Center, Columbus
Alle aldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT04567706

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

RekruttererFase 3
  • Ohio State University Wexner Medical Center, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 17. des. 2025 · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Columbus
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Rekrutterer
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883

Melanom-studier i andre byer

Andre studier i Columbus

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.